Cigarette smoking abolishes ischemic preconditioning-induced augmentation of endothelium-dependent vasodilation

Hypertension

Volumn 53, Issue 4, 2009, Pages 674-681

  Nakamura, Shuji ^a   Kimura, Masashi ^a   Goto, Chikara ^a   Noma, Kensuke ^a   Yoshizumi, Masao ^a   Chayama, Kazuaki ^a   Kihara, Yasuki ^a   Higashi, Yukihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

circulating progenitor cells; endothelial function; no; Preconditioning; smoking; vascular endothelial growth factor

Indexed keywords

ACETYLCHOLINE; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; VASCULOTROPIN;

ADULT; ARM; ARTICLE; BLOOD FLOW; CELL FUNCTION; CELL MIGRATION; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; ISCHEMIA; ISCHEMIC PRECONDITIONING; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; STEM CELL; STRAIN GAUGE TRANSDUCER; VALIDITY; VASODILATATION;

ACETYLCHOLINE; ADULT; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FOREARM; HEMATOPOIETIC STEM CELLS; HUMANS; INFUSIONS, INTRA-ARTERIAL; ISCHEMIA; ISCHEMIC PRECONDITIONING; MALE; NITROARGININE; NITROPRUSSIDE; PLETHYSMOGRAPHY; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 64849085618     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.126078     Document Type: Article

References (37)

1. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction. J Am Coll Cardiol. 1997;30:970-975.
2. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Kouno Y, Umemura T, Nakamura S, Sato H. Diabetes mellitus prevents ischemic pteconditioning in patients with a first acute anterior myocardial infarction. J Am Coll Cardiol. 2001;38:1007-1011.
3. Murry CE, Jenninis RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
4. Nakano A, Cohen MV, Downey JM. Ischemic preconditioning from basic mechanism to clinical applications. Pharmacol Ther. 2000;86: 263-275.
5. Laude K, Beauchamp P, Thuillez C, Richard V. Endothelial protective effects of preconditioning. Caridivasc Res. 2002;55:466-473.
6. Wang WZ, Guo SZ, Anderson GL, Miller FN. The initiating factors of late preconditioning in skelet al. muscle. J Surg Res. 2001 ;99:92-99.
7. Bolli R. The late phase of preconditioning. Circ Res. 2000;87:972-983.
8. Kloner RA, Lennings RB. Consequences of brief ischemia: stunning, preconditioning and their clinical implications part1. Circulation. 2001; 104:2981-2989.
9. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
10. Drexler H, Horning B. Endothelial dysfunction in human disease. J Mol Cell Cardiol. 1999;31:51-60.
11. Higashi Y, Sasaki S, Kurisu S, Yoshimizu A, Ssaki N, Matsuura H, Kajiyama G, Oshima T. Regular aerobic exercise augments endotheliumdependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation. 1999;100: 1194-1202.
12. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
13. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endotheliumdependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589-1596.
14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-500.
15. Kimura M, Goto C, Umemura T, Ueda K, Nishioka K, Jitsuiki D, Yoshizumi M, Chayama K, Higashi Y. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells. Arterioscler Thromb Vasc Bid. 2007 ;27:1403-1410.
16. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149-2155.
17. Lavi S, Prasad A, Yang EH, Mathew V, Simari RD, Rihal CS, Lerman LO, Lerman A. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation. 2007;115:2621-2627.
18. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EA, Pehrsson K, Sandoe E, Simes J, Wilcox RG, Verstraete M, von der Lippe G, Van der Werf T. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation. 1993;87:53-58.
19. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL, for the TIMI investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, phase II. Circulation. 1992;85:1254-1264.
20. Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 2000;477:258-262.
21. Laude K, Richard V, Henry JP, Lallemand F, Thuillez C. Evidence against a role of inducible nitric oxide synthase in the endothelial protective effects of delayed preconditioning. Brit J Pharmacol. 2000; 130: 1547-1552.
22. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 1998;93:325-338.
23. Olfert IM, Breen EC, Mathieu-Costello O, Wagner PD. Skelet al. muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J AppI Physiol. 2001;91:1176-1184.
24. Gustafsson T, Kraus WE. Exercise-induced angiogenesis-related growth and transcription factors in skelet al. muscle, and their modification in muscle pathology. Front Biosci. 2001;6:D75-D89.
25. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964-3972.
26. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
27. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, lino S, Inden Y, Murohara T. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol. 2004;24:1442-1447.
28. Edirisinghe I, Yang SR, Yao H, Rajendrasozhan S, Caito S, Adenuga D, Wong C, Rahman A, Phipps RP, Jin ZG, Rahman I. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J. 2008;22: 2297-2310.
29. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131:1557-1566.
30. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2 (+) AC133 (+) endothelial precursor cells. Circ Res. 2001;88: 167-174.
31. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, Rossig L, Corbaz A, Chvatchko Y, Zeiher AM, Dimmeler S. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation. 2005;111:1184-1191.
32. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol. 2006;48:1579-1587.
33. Wu Y, Ip JE, Huang J, Zhang L, Matsushita K, Liew CC, Pratt RE, Dzau VJ. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res. 2006;99: 315-322.
34. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004; 109:2058-2067.
35. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45:1219-1222.
36. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356:911-920.
37. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 2001;103: 1624-1630.